Dividend Daily RSS Feed RSS
Dividend Stocks

The Dividend Daily

Dividend stocks - News, notes, updates, and analysis, delivered fresh daily

Eli Lilly Drops on Drug Deaths News (LLY)

By Dividend.com Staff
August 27th, 2008

eli-lilly-drops-on-drug-deaths-news-lly

Eli Lilly (LLY) is down today on news of four patient deaths that were taking diabetes drug Byetta, a drug developed with partner Amylin Pharmaceuticals.

Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.

Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!

Comments on this Article COMMENTS ON THIS ARTICLE

One Response to “Eli Lilly Drops on Drug Deaths News (LLY)”

  1. Daniel Haszard Says:
    August 27th, 2008 at 1:08 pm

    Zyprexa has generated a lot of bad press for Eli Lilly and they still have unresolved Zyprexa settlement claims.
    Eli Lilly is ‘reaping the whirlwind’ for aggressive marketing of Zyprexa that has caused suffering and deaths.
    Zyprexa is being avoided by doctors they aren’t prescribing it for new patients at all anymore.
    –
    Daniel Haszard 4 year Zyprexa patient who got diabetes from it.

Leave a Reply

Your Comments:

Please type the Security Words below:

About This Article ABOUT THIS ARTICLE

You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Disclaimer: Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.